期刊文献+

益气健脾方对香烟烟雾暴露小鼠的肺保护作用及潜在机制

Protective Effect of Yiqi Jianpi Recipe on Lung Injury in Mice Exposed to Cigarette Smoke and Its Potential Mechanism
下载PDF
导出
摘要 [目的]初步探讨益气健脾方对香烟烟雾(cigarette smoke,CS)暴露小鼠肺损伤的作用及潜在机制。[方法]60只C57BL/6小鼠随机分为正常组、模型组、预防组、治疗组和防治组。除正常组外,所有小鼠均接受为期4周的CS暴露,其中预防组、防治组分别在暴露初期接受4周及8周的益气健脾方干预,治疗组则于暴露结束后接受4周干预。记录各组小鼠一般情况,苏木精-伊红(hematoxylin-eosin,HE)染色观察肺组织病理学改变;吉姆萨染色观察肺泡灌洗液细胞分类并计数;原位末端转移酶标记(terminal-deoxynucleoitidyl transferase mediated nick end labeling,TUNEL)检测肺组织凋亡细胞DNA片段,免疫印迹检测B淋巴细胞瘤-2(B-cell lymphoma-2,Bcl-2)、Bcl-2相关X蛋白(Bcl-2 associated X,Bax)、胱天蛋白酶-3(cysteine aspartate proteinase-3,caspase-3)、激活型caspase-3(cleaved-caspase-3)、多聚ADP核糖聚合酶1[poly(ADP-ribose)polymerase 1,PARP1]、激活型PARP1(cleaved-PARP1)蛋白表达。[结果]至第4周,模型组小鼠生存率仅为72.72%;至第8周,模型组小鼠体质量最低(P<0.05),肺组织内可见明显炎性细胞浸润及结构破坏。与模型组比较,益气健脾方干预的三组小鼠体质量增加,死亡率降低(P<0.05),肺部炎症浸润及组织损伤均有所减轻(P<0.05),其中以防治组改善最为显著(P<0.01)。与正常组比较,模型组小鼠细胞凋亡指数明显增加(P<0.01),中药干预后则显著减少(P<0.01)。与正常组比较,模型组小鼠肺组织Bcl-2表达减少,Bax表达增多,Bcl-2/Bax比值下调,并且caspase-3、PARP1蛋白及其活化水平均上调(P<0.01,P<0.05)。与模型组比较,经中药干预8周后,小鼠肺组织中Bcl-2表达增加,Bax表达减少,Bcl-2/Bax比值上调,而Bax、caspase-3、cleaved-caspase-3、cleaved-PARP1表达均降低(P<0.05,P<0.01)。[结论]益气健脾方可有效减轻CS暴露造成的小鼠肺组织损伤及炎症反应,其机制可能与抑制Bcl-2-Bax/caspase-3/PARP1细胞凋亡通路相关。 [Objective]To investigate the effect of Yiqi Jianpi Recipe(YQJPR)on lung injury in mice exposed to cigarette smoke(CS),and its potential mechanism.[Methods]Sixty C57BL/6 mice were randomly divided into normal group,model group(CS),prevention group(CS+P),treatment group(CS+T)and prevention and treatment group(CS+P+T).Except for normal group,all mice were exposed to CS for 4 weeks,CS+P group and CS+P+T group were subjected to YQJPR for 4 weeks and 8 weeks from CS exposure beginning,while CS+T group received YQJPR for 4 weeks after CS exposure.The general condition of mice in each group was recorded.Hematoxylin-eosin(HE)staining and Giemsa staining were respectively used to observe the lung histopathology and the classification and counts of inflammatory cells in alveolar lavage fluid.Terminal-deoxynucleoitidyl transferase mediated nick end labeling(TUNEL)apoptosis assay was used to detect the DNA fragments of apoptotic cells in lung tissues,and Western blot was used to assess the protein expression of B-cell lymphoma-2(Bcl-2),Bcl-2 associated X(Bax),cysteine aspartate proteinase-3(caspase-3),cleaved-caspase-3,poly(ADP-ribose)polymerase 1(PARP1)and cleaved-PARP1.[Results]At 4th week,the survival rate of mice in model group was only 72.72%;at 8th week,compared with other groups,the mice in model group had decreased body weights with increased mortalities(P<0.05).HE staining showed obvious inflammatory cells infiltrations and structural damages in lung tissue.Compared with model group,the mice in three groups dministrated with YQJPR had gained body weights and reduced mortalities(P<0.05).Meanwhile,their lung inflammatory infiltrations and tissue damages were alleviated(P<0.05).As expected,the pathological changes had most significant improvement in mice with 8-week YQJPR administration(P<0.01).TUNEL apoptosis assay showed that compared with normal group,the apoptotic index in model group was significantly increased(P<0.01),while in mice with YQJPR,all three groups had a lower apoptosis rate in lung(P<0.01).Western blot showed that compared with normal group,the expression level of Bax was increased and the expression level of Bcl-2 was decreased in model group.The ratio of Bcl-2 to Bax was also decreased,caspase-3,PARP1 and their activation proteins were totally upregulated(P<0.01,P<0.05).Intriguingly,compared with model group,8-week treatment of YQJPR could inhibit the expression of Bax,caspase-3,cleaved caspase-3,cleaved PARP1,whereas promote the expression of Bcl-2 and raise the ratio of Bcl-2 to Bax(P<0.05,P<0.01).[Conclusion]YQJPR could effectively protect the lung injury and inflammation from CS exposure in mice,the mechanism may relate to the inhibition of apoptosis pathway of Bcl-2-Bax/caspase-3/PARP1.
作者 王璐 周林水 董泉明 王真 WANG Lu;ZHOU Linshui;DONG Quanming(The First Affiliated Hospital of Zhejiang Chinese Medical University(Zheji-ang Provincial Hospital of Traditional Chinese Medicine),Hangzhou(310006),China)
出处 《浙江中医药大学学报》 CAS 2023年第11期1235-1242,共8页 Journal of Zhejiang Chinese Medical University
基金 浙江省中医药科技计划项目(2023ZR020) 浙江省自然科学基金项目(LQ20H270014) 国家自然科学基金项目(82104587)。
关键词 益气健脾 慢性阻塞性肺疾病 香烟烟雾 细胞凋亡 CASPASE-3 PARP1 tonifying Qi and invigorating the spleen chronic obstructive pulmonary disease cigarette smoke cell apoptosis caspase-3 PARP1
  • 相关文献

参考文献7

二级参考文献52

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 2邡筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:57-58.
  • 3Celli BR, Cote CC, Marin JM, et al. The body-mass index,airflow obstruction dyspnea and exercise capacity index in chronic obstruction pulmonary disease [J]. N Engl J Med, 2004, 350(10): 1005-1012.
  • 4Celli BR, MacNee W, ATSLERS Task Force. Standards for the diagnosis and treatment of patients with C()PD: a summary of the ATS/ERS position paper[J]. Eur Respir J, 2004, 23(6): 932-946.
  • 5Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population based survey [J ]. Am J Respir Crit Care Med, 2007, 176(11): 753-760.
  • 6宫静.林周胜,张伟,等.培土生金法埘慢性阻塞性肺疾病稳定期生存质量与营养状态的影响[J].中西中医,2011.27(1):13-16.
  • 7傅开龙,卢健,焦扬.99例慢性阻塞性肺疾病中医证候横断面调查[J].中医杂志,2007,48(10):923-926. 被引量:30
  • 8World Health Organization.The global burden of disease:2004 update.The World Health Organization Website.http://www.Who. Int/heahhinfo/global-burden-disease/2004-report-update/en/ index.htm.2004.Accessed December 2006.
  • 9Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey.Am J Respir Crit Care Med,2007,176:753-760.
  • 10Peter M A Calverley,Julie A Anderson,Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive nulmorrarv disease.N Eng_l J Med.2007.356:775-789.

共引文献249

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部